Clostridium Difficile Associated Diarrhea (CDAD)

Clostridium Difficile Associated Diarrhea (CDAD) is the indication for 2 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as: Diarrhea caused by Clostridium Difficile · Clostridium Difficile-Associated Diarrhea · Clostridium Difficile Diarrhea · Clostridium Difficile Associated Diarrhea · Diarrhoea, Clostridium Difficile
Classified under: Digestive System Diseases
Infections
Signs, Symptoms, and General Pathologies
Indicated drugs: Fidaxomicin
Vancomycin

Resolves to

Vocabularies

ICD-10A04.7SNOMED CT423590009MedDRA10006833UMLSC0235952

What you can answer from here — as of October 25, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

19Clinical trialsPhase, status and sponsor resolved per trial

2Boxed warningsLabel boxed warnings that name this condition

49Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Clostridium Difficile Associated Diarrhea (CDAD) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.